Prof. Hans Stauss
Professor Stauss is the Director of the UCL Institute of Immunity & Transplantation. The research goals of the Institute include enhancing immunity for the treatment of cancer and chronic infection, developing new immune-intervention approaches to treat autoimmune conditions and transplant rejection, and applying innovative cell and gene therapy strategies to manage patients with inherited diseases.
Hans leads a research group that has focused for many years on T cell biology and cancer immunology, and more recently his group has worked on the genetic engineering of regulatory T cells. He has an international reputation as a researcher in cancer immunotherapy. His group has identified protein structures of cancer cells that can be recognised by immune cells and serve as targets for gene engineered T cells to achieve cancer cell killing. This research has led to first in man clinical trials in cancer patients.